Menlo Park, California, and Charenton-le-Pont, France (September 27, 2023 – 11:00 am PST) – Meta Platforms, Inc. and EssilorLuxottica introduced their next generation of smart glasses, the Ray-Ban Meta smart glasses, today during the annual Meta Connect event.

Using this staggered approach, as of 2026 the Board of Directors will be partly renewed every year and fully renewed at the end of a three-year period. The mandates of Margot Bard and Sébastien Brown, Directors representing employees, will end on September 21, 2024 when the Group’s Works Council will appoint two Directors representing employees for a three-year term.

We are pleased to announce the holding of an online event “SIGMA STAGE ONLINE”, which is a presentation of new products. It will be held on Thursday, June 8th, 2023, from JST 21:00.

The SIGMA 70-200mm F2.8 DG DN OS | Sports is a large-aperture zoom lens for full-frame mirrorless cameras. In addition to the expressive imaging capabilities owing to the latest optical design, the lens offers a high level of performance and features that meet the expectations of professionals in both still and video, including high-speed autofocus with HLA (High-response Linear Actuator)

SIGMA Corporation (Headquarters: Kawasaki, Kanagawa Prefecture; CEO: Kazuto Yamaki) is pleased to announce its sponsorship of "KYOTOGRAPHIE 2024" and "KG+2024," taking place in Kyoto from April 13th (Saturday) to May 12th (Sunday), 2024.

Charenton-le-Pont, France and Milan, Italy (March 7, 2024) - EssilorLuxottica and Dolce&Gabbana, today, announce the early renewal of their licensing agreement for the development, production and worldwide distribution of prescription frames and sunglasses under the Dolce&Gabbana brand.

Charenton-le-Pont, France (May 02, 2024) – EssilorLuxottica continues its long-standing partnership established more than a decade ago with the European Academy of Optometry and Optics (EAOO), by participating in its 15th annual conference on May 10-12, 2024, in Helsinki, Finland. The Company’s expertise in myopia management and advances in clinical refraction will take centre stage this year.